J. Joyce

发表

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

R. Varadarajan, J. Shiver, M. Citron, 2010, Proceedings of the National Academy of Sciences.

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

Henryk Mach, Norman L. Letvin, Michelle A. Lifton, 2002, Nature.

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast.

K. Jansen, J. Joyce, J. Cook, 1997, The Journal of infectious diseases.

Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.

E. Miranda, R. Varadarajan, W. Schleif, 2006, The Biochemical journal.

Solution State Characterization of Amyloid β-Derived Diffusible Ligands

R. Hepler, J. Joyce, P. Shughrue, 2006 .

HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.

G. McGaughey, R. Freidinger, J. Shiver, 2003, Biochemistry.

Expression and Purification of Recombinant Tick Anticoagulant Peptide (Y1W/D10R) Double Mutant Secreted bySaccharomyces cerevisiae☆

J. Joyce, M. Sardana, J. Cook, 1998 .

Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody.

J. Shiver, A. Finnefrock, J. Joyce, 2007, Journal of the American Chemical Society.

An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions

J. Shiver, J. Joyce, M. Chastain, 2008, Proceedings of the National Academy of Sciences.

Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

E. Ottinger, J. Heinrichs, M. Batzloff, 2013, Human vaccines & immunotherapeutics.

Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.

J. Shiver, V. Garsky, Qinjian Zhao, 2009, Virology.

The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat

D. Montefiori, J. Shiver, C. Labranche, 2020, Proceedings of the National Academy of Sciences.

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp 41 epitope

D. Hazuda, R. Cortese, G. Ciliberto, 2005 .

Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

J. Condra, A. Pessi, J. Joyce, 2008, AIDS research and human retroviruses.

Large-scale purification and characterization of recombinant tick anticoagulant peptide.

F. J. Bailey, J. Joyce, C. Przysiecki, 1992, Journal of chromatography.

Amino acid analysis of peptide loading ratios in conjugate vaccines: a comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methods.

R. Hepler, J. Joyce, D. Nahas, 2008, Bioconjugate chemistry.

Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.

M. Rosolowsky, K. Jansen, J. Joyce, 1995, Virology.

A Novel Process for the Large-Scale Purification of Recombinant Tick Anticoagulant Peptide Using Perfusion Chromatography

F. J. Bailey, J. Joyce, E. Lehman, 1993, Bio/Technology.

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.

K. Jansen, Qiuwei Xu, G. Pier, 2003, Carbohydrate research.

Venous and aortic porcine endothelial cells cultured under standardized conditions synthesize heparan sulfate chains which differ in charge.

J. Joyce, L. Lowe-Krentz, 1991, Analytical biochemistry.

Synthetic peptide vaccines: the quest to develop peptide vaccines for influenza, HIV and Alzheimer's disease.

G. Ciliberto, J. Shiver, Xiao-ping Liang, 2009, Advances in experimental medicine and biology.

The L1 Major Capsid Protein of Human Papillomavirus Type 11 Recombinant Virus-like Particles Interacts with Heparin and Cell-surface Glycosaminoglycans on Human Keratinocytes*

K. Jansen, J. Joyce, J. Cook, 1999, The Journal of Biological Chemistry.

Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.

K. Jansen, R. Hepler, J. Joyce, 1999, Protein expression and purification.

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.

J. Shiver, M. Citron, J. Joyce, 2009, Vaccine.

Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.

F. J. Bailey, C. Dunwiddie, M. Jacobson, 1993, Protein expression and purification.

A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.

Steven L. Cohen, A. Woods, K. Jansen, 2006, Vaccine.

A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope.

Gennaro Ciliberto, Peter S Kim, Simon Lennard, 2005, Proceedings of the National Academy of Sciences of the United States of America.

A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines

Huanming Yang, I-Ming Wang, Shiyu Wang, 2018, Front. Immunol..

Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads

G. McGaughey, E. Ottinger, M. Citron, 2010, The Journal of Biological Chemistry.

Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization.

J. Shiver, R. Steigbigel, P. Goepfert, 2003, The Journal of infectious diseases.

Structure-Function Relationships in the Neuropeptide S Receptor

Christopher M. Tan, D. Slipetz, M. Crackower, 2006, Journal of Biological Chemistry.

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys.

J. Shiver, V. Garsky, J. Condra, 2004, Vaccine.

A Novel Staphylococcus aureus Vaccine: Iron Surface Determinant B Induces Rapid Antibody Responses in Rhesus Macaques and Specific Increased Survival in a Murine S. aureus Sepsis Model

Charles Y. Tan, W. Mcclements, K. Jansen, 2006, Infection and Immunity.

Immunogenicity and Protective Efficacy of Bacillus anthracis Poly-γ-d-glutamic Acid Capsule Covalently Coupled to a Protein Carrier Using a Novel Triazine-based Conjugation Strategy*

Qiuwei Xu, M. Bruner, R. Hepler, 2006, Journal of Biological Chemistry.

An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.

J. Shiver, G. Heidecker, J. Joyce, 2001, Protein expression and purification.

Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine.

R. Hepler, J. Joyce, A. Friedlander, 2016, Vaccine.

Solution state characterization of amyloid beta-derived diffusible ligands.

R. Hepler, J. Joyce, P. Shughrue, 2006, Biochemistry.

Progress towards the development of a HIV-1 gp41-directed vaccine.

G. McGaughey, R. Freidinger, J. Shiver, 2004, Current HIV research.

Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

J. Bodmer, J. Heinrichs, J. Joyce, 2014, Vaccine.

Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles.

K. Jansen, J. Joyce, J. Cook, 2001, Vaccine.

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

D. Montefiori, J. Shiver, A. Finnefrock, 2010, Proceedings of the National Academy of Sciences.

Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae.

C. Dunwiddie, J. Joyce, M. Sardana, 1992, Protein expression and purification.

Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys.

G. Ruthel, N. Vietri, R. Hepler, 2012, Vaccine.

Oligomers of β-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model

Nicole Bowles, Joseph G. Joyce, R. Hepler, 2010, Experimental Neurology.

Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells

Xue-jun Fan, J. Joyce, D. Casimiro, 2015, mAbs.

Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies*

D. Montefiori, R. Varadarajan, C. Labranche, 2016, The Journal of Biological Chemistry.

Eliciting broadly neutralizing antibodies against HIV-1 1 Structure Based Design of Cyclically Permuted HIV-1 gp 120 Trimers That Elicit Neutralizing Antibodies

D. Montefiori, R. Varadarajan, C. Labranche, 2016 .

Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse models.

J. Joyce, Julie M. Skinner, S. Curry, 2022, Vaccine.

Chromatographic separation of low-molecular-mass recombinant proteins and peptides on Superdex 30 prep grade.

J. Joyce, J. Cook, C. Przysiecki, 1994, Journal of chromatography. B, Biomedical applications.

Staphylococcus aureus capsule type 8 antibodies provide inconsistent efficacy in murine Models of staphylococcal infection

Charles Y. Tan, J. Joyce, L. Cope, 2009, Human vaccines.

Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons

E. Chen-Dodson, G. Heidecker, J. Joyce, 2010, Neurobiology of Aging.

The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.

D. Henze, G. Krafft, J. Joyce, 2006, Current topics in medicinal chemistry.

Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.

G. Ciliberto, J. Shiver, W. Schleif, 2004, Journal of immunological methods.

Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro

J. Shiver, V. Garsky, M. Citron, 2002, The Journal of Biological Chemistry.

Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin*

V. Garsky, J. Shafer, J. Joyce, 1998, The Journal of Biological Chemistry.

Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation

James M. Wagner, Amy S. Espeseth, A. Espeseth, 2018, Protein science : a publication of the Protein Society.

Pushing the envelope on HIV-1 neutralization

J. Meulen, J. Joyce, 2010, Nature Biotechnology.

Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.

J. Bodmer, J. Heinrichs, J. Joyce, 2016, Methods in molecular biology.

Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.

K. Jansen, Qiuwei Xu, G. Pier, 2003, Carbohydrate research.

Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41

J. Condra, A. Finnefrock, M. Luftig, 2009, mAbs.